Eli Lilly and vs Thermo Fisher Scientific: Fair Value & Quality
Both stocks run through our valuation models. Here is how Eli Lilly and (LLY) and Thermo Fisher Scientific (TMO) compare, as of Aug 16, 2026.
As of Aug 16, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Eli Lilly and trades at $1,180 versus a fair value of $389 (-67%), while Thermo Fisher Scientific trades at $588 versus $308 (-48%).
Eli Lilly and
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,180
Fair Value$389
Quality69/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$588
Fair Value$308
Quality63/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Eli Lilly andThermo Fisher Scientific
Valuation
42.2×P/E (TTM)29.5×
14.67×P/S (TTM)4.41×
39.94×P/B3.74×
30.2×EV/EBITDA20.0×
1.54×PEG1.74×
0.5%Dividend yield0.3%
$6.23Dividend per share$1.76
Profitability
35%Net margin15%
49%Operating margin18%
107%Return on equity14%
21%Return on assets5%
Growth
56%Revenue growth (YoY)6%
31.7%Avg. growth/yr (3Y)-0.3%
21.6%Avg. growth/yr (5Y)6.7%
Balance & size
1.54×Debt / equity0.67×
$1.1TMarket cap$199B
mixedGrowth qualityhealthy
Eli Lilly and leads: 9 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Eli Lilly andof which business quality 65 · market factors 81Thermo Fisher Scientificof which business quality 60 · market factors 67
ProfitabilityMargins and returns on capital today
85
43
Quality GrowthAre margins and returns improving?
86
31
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
15
79
Low VolatilityCalm price path (market factor)
77
69
MomentumPrice trend over the last 3–12 months (market factor)
76
65
52W MomentumDistance to the 52-week high (market factor)
95
68
Net IssuanceBuybacks instead of dilution
93
97
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Eli Lilly and
DCF Models$334
Earnings-Based$239
Dividend Discount$115
Multiples$358
Asset-Based$19.94
Growth DCF$187
Economic Profit$347
Growth Earnings$375
26 of 26 models see the stock below the current price.
Thermo Fisher Scientific
DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Eli Lilly and
Bear $216Fair Value $389Bull $582
$1,180 = current price (white tick)
Thermo Fisher Scientific
Bear $171Fair Value $308Bull $385
$588 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Eli Lilly and · Health Care
Quality score69 · Top 25%
Fair value upside-67% · bottom 25%
Thermo Fisher Scientific · Health Care
Quality score63 · Top 25%
Fair value upside-48% · below median
Bottom line
As of Aug 16, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Eli Lilly and trades at $1,180 versus a fair value of $389 (-67%), while Thermo Fisher Scientific trades at $588 versus $308 (-48%).
Eli Lilly and has the higher quality score (69/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
